Ughasoro Maduka Donatus, Akpeh James Onuorah, Echendu Nneamaka, Okpala Somkene, Mgbachi Nneka Getrude, Okanya Ogochukwu Chinelo, Onwujekwe Obinna Emmanuel
Department of Paediatrics, University of Nigeria Enugu Campus, Enugu, Nigeria.
Department of Paediatrics, University of Nigeria Teaching Hospital, Ituku/Ozalla, Enugu, Nigeria.
Pharmacoecon Open. 2021 Dec;5(4):755-764. doi: 10.1007/s41669-021-00259-6. Epub 2021 Apr 8.
Acute tonsillitis has become one of the main reasons why children visit healthcare facilities in Nigeria. Presently, there is no information on the costs of its treatment, and this study aimed at determining these costs.
The study was conducted in two hospitals located in southeast Nigeria. The information was obtained in two ways: (1) retrospectively from the medical records of children treated for acute tonsillitis over a period of 5 years and (2) cross-sectionally from children who presented with complaints of acute tonsillitis over a period of 7 months. The information obtained was the costs of self-medication and hospital treatment, and the payment mechanisms used to settle these costs. The human capital method approach was used to estimate the indirect cost (loss in productivity) from the caregivers' absenteeism from work.
The mean costs of self-medication and hospital treatment for acute tonsillitis in children were €3.85 and €13.48, respectively. The indirect cost was €11.31. The mean total cost of treatment of acute tonsillitis was €23.80. The proportion of households that suffered catastrophic health expenditure (CHE) from the treatment of acute tonsillitis was 55 (55%). CHE was highest [22 (91.7%)] in the lowest socio-economic quartile compared to households in the highest quartile [4 (16.7%)], and the difference was statistically significant (p = 0.02). Of the 72 participants whose payment mechanisms were documented, the proportion who paid out of pocket was 53 (73.6%), and 19 (26.4%) used the National Health Insurance Scheme.
The costs of treatment for children with acute tonsillitis were high, and most of these costs were settled out-of-pocket. The costs for laboratory investigations, drugs, and productivity loss contributed to these high costs. There is a need to cover the costs of non-surgical treatment of acute tonsillitis in social health insurance and improve efforts to increase the coverage of the health insurance scheme.
急性扁桃体炎已成为尼日利亚儿童前往医疗机构就诊的主要原因之一。目前,尚无关于其治疗费用的信息,本研究旨在确定这些费用。
该研究在尼日利亚东南部的两家医院进行。信息通过两种方式获取:(1)回顾性地从5年内接受急性扁桃体炎治疗的儿童病历中获取,(2)横断面地从7个月内出现急性扁桃体炎症状的儿童中获取。获取的信息包括自我治疗和住院治疗的费用,以及用于支付这些费用的支付机制。采用人力资本法估算照顾者因缺勤而导致的间接成本(生产力损失)。
儿童急性扁桃体炎的自我治疗和住院治疗平均费用分别为3.85欧元和13.48欧元。间接成本为11.31欧元。急性扁桃体炎治疗的平均总费用为23.80欧元。因急性扁桃体炎治疗而遭受灾难性医疗支出(CHE)的家庭比例为55(55%)。与最高社会经济四分位数的家庭相比,最低社会经济四分位数的家庭中CHE最高[22(91.7%)],差异具有统计学意义(p = 0.02)。在记录了支付机制的72名参与者中,自掏腰包支付的比例为53(73.6%),19(26.4%)使用了国家健康保险计划。
急性扁桃体炎患儿的治疗费用较高,且大部分费用是自掏腰包支付。实验室检查、药品和生产力损失的费用导致了这些高额费用。有必要在社会医疗保险中涵盖急性扁桃体炎非手术治疗的费用,并加大力度提高医疗保险计划的覆盖范围。